Lite Strategy, Inc. Retained Earnings
Lite Strategy, Inc. (LITS) had Retained Earnings of -$462.30 million as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-05-13
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$462.30M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$438.60M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$407.80M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$404.16M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-03-31 | -$462.30M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | -$438.60M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | -$407.80M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$404.16M 10-Q · filed 2026-05-13 | |
| 2025-03-31 | -$401.48M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | -$398.90M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | -$396.23M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$388.22M 10-K · filed 2025-09-26 | |
| 2024-03-31 | -$369.81M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$360.69M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | -$349.62M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$406.00M 10-K · filed 2024-09-19 | |
| 2023-03-31 | -$395.97M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$380.53M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | -$390.78M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$374.16M 10-K · filed 2023-09-26 | |
| 2022-03-31 | -$358.10M 10-Q · filed 2022-05-23 | |
| 2021-12-31 | -$349.37M 10-Q/A · filed 2022-05-23 | -$345.45M 10-Q · filed 2022-02-10 |
| 2021-09-30 | -$337.21M 10-Q/A · filed 2022-05-23 | -$339.69M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$319.70M 10-K · filed 2022-09-08 | -$327.81M 10-K · filed 2021-09-02 |
| 2021-03-31 | -$322.09M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | -$285.70M 10-Q/A · filed 2022-05-23 | -$290.78M 10-Q · filed 2021-02-04 |
| 2020-09-30 | -$277.68M 10-Q/A · filed 2022-05-23 | -$279.33M 10-Q · filed 2020-11-10 |
| 2020-06-30 | -$278.39M 10-K/A · filed 2022-05-23 | -$277.23M 10-K · filed 2020-09-09 |
| 2020-03-31 | -$258.76M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | -$254.43M 10-Q · filed 2020-02-06 | |
| 2019-09-30 | -$234.21M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | -$231.22M 10-K · filed 2020-09-09 | |
| 2019-03-31 | -$234.27M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$216.92M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | -$228.94M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$214.40M 10-K · filed 2019-08-28 | |
| 2018-03-31 | -$195.15M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | -$189.20M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | -$183.12M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | -$174.33M 10-K · filed 2018-08-30 | |
| 2017-03-31 | -$169.99M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | -$169.39M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | -$181.27M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$177.00M 10-K · filed 2017-09-05 | |
| 2016-03-31 | -$171.23M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | -$165.86M 10-Q · filed 2016-02-05 | |
| 2015-09-30 | -$160.76M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | -$156.14M 10-K · filed 2016-09-06 | |
| 2015-03-31 | -$150.48M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$141.55M 10-Q · filed 2015-02-06 | |
| 2014-09-30 | -$132.44M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | -$123.44M 10-K · filed 2015-09-02 | |
| 2014-03-31 | -$114.90M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | -$107.52M 10-Q · filed 2014-02-11 | |
| 2013-09-30 | -$101.19M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | -$96.30M 10-K · filed 2014-09-09 | |
| 2013-03-31 | -$93.08M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | -$90.33M 10-Q · filed 2013-02-12 | |
| 2012-09-30 | -$87.58M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | -$85.11M 10-K · filed 2013-09-18 | |
| 2012-03-31 | -$83.01M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | -$80.74M 10-Q · filed 2012-02-09 | |
| 2011-09-30 | -$79.20M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$77.59M 10-K · filed 2012-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |